Research Article
Predictors of Long-Time Survivors in Nonmetastatic Colorectal Signet Ring Cell Carcinoma: A Large Population-Based Study
Table 2
Logistic regression analysis to identify predictors of long-time survivors in nonmetastatic colorectal SRCC† in the training cohort.
| Variables | Unadjusted logistic regression | Adjusted logistic regression | OR‡ (95% CI§) | | OR (95% CI) | |
| Age | | | | | ≤40 | Reference | | Reference | | 41-55 | 1.69 (1.07-2.72) | 0.028 | 1.29 (0.79-2.16) | 0.320 | 56-70 | 1.35 (0.87-2.14) | 0.186 | 0.79 (0.49-1.30) | 0.338 | >70 | 1.22 (0.79-1.91) | 0.382 | 0.69 (0.42-1.15) | 0.146 | Race | | | | | Black | Reference | | Reference | | White | 2.29 (1.47-3.69) | <0.001 | 2.57 (1.60-4.30) | <0.001 | Other | 1.37 (0.75-2.50) | 0.305 | 1.84 (0.97-3.54) | 0.064 | Unknown | 1.51 (0.07-12.41) | 0.724 | 1.76 (0.08-15.05) | 0.634 | Sex | | | | | Male | Reference | | | | Female | 1.18 (0.95-1.47) | 0.14 | | | Marital status | | | | | Unmarried | Reference | | Reference | | Married | 1.42 (1.13-1.79) | 0.003 | 1.34 (1.04-1.73) | 0.023 | Unknown | 0.80 (0.42-1.43) | 0.475 | 0.66 (0.33-1.25) | 0.220 | Tumor grade | | | | | Well/moderately | Reference | | Reference | | Poorly/undifferentiated | 0.54 (0.36-0.80) | 0.002 | 0.73 (0.48-1.12) | 0.149 | Unknown | 0.80 (0.49-1.32) | 0.380 | 0.98 (0.56-1.72) | 0.951 | Tumor size (cm) | | | | | ≤ 4 | Reference | | | | 4.1-6 | 0.79 (0.59-1.06) | 0.117 | | | >6 | 0.79 (0.60-1.04) | 0.099 | | | Unknown | 0.74 (0.50-1.08) | 0.126 | | | Tumor location | | | | | Right colon | Reference | | Reference | | Left colon | 0.97 (0.70-1.32) | 0.840 | 1.04 (0.72-1.47) | 0.848 | Rectum | 0.69 (0.51-0.92) | 0.012 | 0.91 (0.53-1.53) | 0.719 | Unknown | 0.96 (0.39-2.19) | 0.931 | 1.44 (0.56-3.44) | 0.429 | Number of lymph node examined | | | | | < 12 | Reference | | | | ≥ 12 | 1.08 (0.84-1.39) | 0.545 | | | Unknown | 0.67 (0.19-1.90) | 0.483 | | | T stage | | | | | T4 | Reference | | Reference | | T3 | 2.43 (1.85-3.22) | <0.001 | 2.13 (1.59-2.88) | <0.001 | T2 | 3.51 (2.15-5.70) | <0.001 | 2.42 (1.43-4.11) | 0.001 | Tis-T1 | 4.43 (2.79-7.06) | <0.001 | 3.64 (2.07-6.45) | <0.001 | N stage | | | | | N2 | Reference | | Reference | | N1 | 1.91 (1.41-2.59) | <0.001 | 2.07 (1.50-2.87) | <0.001 | N0 | 3.35 (2.57-4.38) | <0.001 | 2.87 (2.09-3.96) | <0.001 | Primary tumor treatment | | | | | No | Reference | | Reference | | Surgery | 14.44 (4.49-88.28) | <0.001 | 21.38 (6.28-134.38) | <0.001 | Local tumor excision | 30.50 (6.63-223.18) | <0.001 | 22.80 (4.68-172.76) | <0.001 | Radiation | | | | | No/unknown | Reference | | Reference | | Yes | 0.64 (0.46-0.87) | 0.006 | 0.70 (0.39-1.25) | 0.234 | Chemotherapy | | | | | No/unknown | Reference | | Reference | | Yes | 0.70 (0.56-0.88) | 0.002 | 1.00 (0.74-1.35) | 0.984 |
|
|
†SRCC: signet ring cell carcinoma; ‡OR: odds ratio; §CI: confidence interval.
|